The US FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients.

Federal regulators have warned a Waco company that its human amniotic products are “unlicensed” and “unapproved,” and that ...

In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...

French pharmaceutical giant Sanofi has received a warning letter from the U.S. Food and Drug Administration following an inspection at its drug manufacturing facility in Framingham.

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

The FDA is putting Atara’s active Investigational New Drug applications on hold due to manufacturing concerns at a ...

VectorBuilder's partner, Ucello, announced that its CD19-targeting umbilical cord blood-derived allogeneic CAR-T cell therapy ...

For many, Lay’s potato chips are a go-to snack. Recently, a serious recall has raised concerns for consumers, especially ...

The FDA first announced on December 18, 2024, that Frito-Lay issued a recall on a “limited number” of the 13 oz bags of chips ...

adding that there has been "no interruption" to manufacturing or the supply of drugs as a result of the FDA warning letter.

In this interview, we explore the key changes shaping the pharmaceutical industry, maintaining compliance across global ...

Atara Biotherapeutics’ layoffs could leave the biotech with around 80 employees. The cuts follow news that the FDA rejected ...